Fig. 1. Chest CT scan shows partial response of multiple lung metastases from advanced papillary thyroid carcinoma five and a half years after treatment with sorafenib.

Int J Thyroidol 2021;14:175-9 https://doi.org/10.11106/ijt.2021.14.2.175

© 2021 Int J Thyroidol